Pages that link to "Q68188433"
Jump to navigation
Jump to search
The following pages link to Nonpalpable, probably benign lesions: role of follow-up mammography (Q68188433):
Displaying 50 items.
- Additional diagnostic value of MRI in patients with suspicious breast lesions based on ultrasound (Q30403614) (← links)
- Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial (Q30424727) (← links)
- Computer-aided classification of breast masses: performance and interobserver variability of expert radiologists versus residents (Q30471855) (← links)
- Breast imaging reporting and data system (BI-RADS). (Q30704127) (← links)
- Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice. (Q30892950) (← links)
- Assessment of 1183 screen-detected, category 3B, circumscribed masses by cytology and core biopsy with long-term follow up data (Q31151261) (← links)
- Effect of patient history data on the prediction of breast cancer from mammographic findings with artificial neural networks (Q31932842) (← links)
- Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 18-month experience with telemedicine screening (Q33368666) (← links)
- Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance? (Q33818628) (← links)
- Value of breast imaging in women with painful breasts: observational follow up study (Q33862598) (← links)
- Follow-up of benign results of stereotactic core breast biopsy (Q33892300) (← links)
- Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667. (Q33922291) (← links)
- Benign core biopsy of probably benign breast lesions 2 cm or larger: correlation with excisional biopsy and long-term follow-up (Q33926086) (← links)
- Successful methods to reduce false-positive mammography interpretations (Q34003506) (← links)
- Clinical management issues in percutaneous core breast biopsy (Q34003522) (← links)
- The role of ultrasound in the diagnosis of breast cancer (Q34050997) (← links)
- Validation of results from knowledge discovery: mass density as a predictor of breast cancer (Q34176979) (← links)
- Nonpalpable, probably benign breast lesions in general practice: the role of follow-up mammography. (Q34215359) (← links)
- Solid Breast Masses Diagnosed as Fibroadenoma at Fine-Needle Aspiration Biopsy: Acceptable Rates of Growth at Long-term Follow-up (Q34266478) (← links)
- The mammographic density of a mass is a significant predictor of breast cancer (Q34534802) (← links)
- Imaging and management of nonpalpable lesions of the breast (Q34662155) (← links)
- Percutaneous image-guided core breast biopsy (Q34738171) (← links)
- Accuracy of short-interval follow-up mammograms by patient and radiologist characteristics (Q35140687) (← links)
- The current role of vacuum assisted breast biopsy system in breast disease. (Q35142094) (← links)
- Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women (Q35181934) (← links)
- Synchronous BI-RADS Category 3 Lesions on Preoperative Ultrasonography in Patients with Breast Cancer: Is Short-Term Follow-Up Appropriate? (Q35813056) (← links)
- Applications and literature review of the BI-RADS classification (Q36108753) (← links)
- What is the optimal threshold at which to recommend breast biopsy? (Q36380607) (← links)
- A history of breast cancer and older age allow risk stratification of mammographic BI-RADS 3 ratings in the diagnostic setting (Q36707490) (← links)
- Positive predictive value of specific mammographic findings according to reader and patient variables (Q37187041) (← links)
- Optimal Policies for Reducing Unnecessary Follow-up Mammography Exams in Breast Cancer Diagnosis (Q37542656) (← links)
- Malignant lesions initially categorized as probably benign breast lesions: retrospective review of ultrasonographic, clinical and pathologic characteristics (Q37720899) (← links)
- US of Breast Masses Categorized as BI-RADS 3, 4, and 5: Pictorial Review of Factors Influencing Clinical Management (Q37787656) (← links)
- Interval growth of probably benign breast lesions on follow-up ultrasound: how can these be managed? (Q38479279) (← links)
- When can stereotactic core biopsy replace excisional biopsy? ? A clinical perspective (Q40424997) (← links)
- Technologic advances in breast imaging. Current and future strategies, controversies, and opportunities. (Q40899513) (← links)
- Stereotaxic needle-core biopsy and fine-needle aspiration biopsy in the diagnosis of nonpalpable breast lesions: controversies and future prospects (Q40914332) (← links)
- Private practice interdisciplinary breast centers: their rationale and impact on patients, physicians, and the health care industry: a bicoastal perspective. (Q41729409) (← links)
- Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study (Q44776178) (← links)
- Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients. (Q48355764) (← links)
- BI-RADS 3: Current and Future Use of Probably Benign (Q49195995) (← links)
- Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features. (Q52586863) (← links)
- Stereotactic breast biopsy is accurate, minimally invasive, and cost effective. (Q53988356) (← links)
- Management of lesions first detected on MRI: what to do? (Q86381414) (← links)
- Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability (Q71141808) (← links)
- Mammographic feature analysis (Q72536098) (← links)
- The roles of needle biopsy and periodic follow-up in the evaluation and diagnosis of breast lesions (Q72536107) (← links)
- Surveillance mammography and stereotactic core breast biopsy for probably benign lesions: a cost comparison analysis (Q73429118) (← links)
- Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose (Q77125624) (← links)
- Gamma emission imaging in the management of breast disorders (Q77184884) (← links)